HomeClinical TopicsNew FDA regulation for improving safety reporting in clinical trials discussed in...
Clinical TopicsDrugs and DevicesNewsWorkplace ManagementPatient SafetyWeb Exclusives

New FDA regulation for improving safety reporting in clinical trials discussed in The New England Journal of Medicine.

The June 8 edition of The New England Journal of Medicine includes “New FDA Regulation to Improve Safety Reporting in Clinical Trials.” Read here.

Previous articleMice study finds genetic link between lung cancer and emphysema
Next articlePCI with stent is a viable option for select group of patients

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content

For Nurse Practitioners

Women suffering from a migraine

Quiz: Migraines and Hormones

Women are 2 to 3 times more likely than men to have migraines.  Decades ago, these were attributed to women’s inability to cope with...

Powered by  HCM   www.HealthComMedia.com

© 2022 HealthCom Media All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder.